OBJECTIVE: Interleukin-7 (IL-7) responses are impaired in CD4(+) T cells from HIV-infected patients, which may play a significant role in the loss of CD4(+) T-cell homeostasis. We set to investigate the nature of IL-7-dependent signaling defects in patients with progressive HIV-1 infection. DESIGN AND METHODS: IL-7 signaling was compared in CD4(+) T cells from viremic patients with a viral load more than 10,000 copies of HIV RNA/ml (n = 23) and from healthy blood donors (n = 23). Phosphorylation of the transcription factor STAT5 on the regulatory serine S726 and the key tyrosine Y694 was monitored by intracellular flow cytometry. Phospho-STAT5 relocalization to the nucleus was analyzed by quantitative immunofluorescence imaging. RESULTS: In control CD4(+) T cells, S726 phosphorylation was mostly constitutive and inducible by IL-7 to a limited extent (1.3x, P < 0.05). In contrast, phosphorylation at Y694 was highly inducible by IL-7 (12.6x, P < 0.0001). Progressive HIV infection led to hyperphosphorylation of both S726 and Y694 in naive CD4(+) T cells, with these changes correlating together (R = 0.66, P = 0.01). Quantitative image analysis revealed an impairment in the nuclear relocalization of both forms of phospho-STAT5 in patient cells (P < 0.005 for S726; P < 0.05 for Y694). The nuclear relocalization defect correlated with increased HLA-DR expression (R = 0.75, P < 0.01), suggesting a role for chronic immune activation in perturbed IL-7 signal transduction. CONCLUSION: HIV infection perturbs IL-7 signaling by impairing the access of STAT5 to the nuclear compartment. This defect may contribute to the loss of CD4(+) T-cell populations in patients with chronically high immune activation.
OBJECTIVE:Interleukin-7 (IL-7) responses are impaired in CD4(+) T cells from HIV-infectedpatients, which may play a significant role in the loss of CD4(+) T-cell homeostasis. We set to investigate the nature of IL-7-dependent signaling defects in patients with progressive HIV-1 infection. DESIGN AND METHODS: IL-7 signaling was compared in CD4(+) T cells from viremic patients with a viral load more than 10,000 copies of HIV RNA/ml (n = 23) and from healthy blood donors (n = 23). Phosphorylation of the transcription factor STAT5 on the regulatory serine S726 and the key tyrosine Y694 was monitored by intracellular flow cytometry. Phospho-STAT5 relocalization to the nucleus was analyzed by quantitative immunofluorescence imaging. RESULTS: In control CD4(+) T cells, S726 phosphorylation was mostly constitutive and inducible by IL-7 to a limited extent (1.3x, P < 0.05). In contrast, phosphorylation at Y694 was highly inducible by IL-7 (12.6x, P < 0.0001). Progressive HIV infection led to hyperphosphorylation of both S726 and Y694 in naive CD4(+) T cells, with these changes correlating together (R = 0.66, P = 0.01). Quantitative image analysis revealed an impairment in the nuclear relocalization of both forms of phospho-STAT5 in patient cells (P < 0.005 for S726; P < 0.05 for Y694). The nuclear relocalization defect correlated with increased HLA-DR expression (R = 0.75, P < 0.01), suggesting a role for chronic immune activation in perturbed IL-7 signal transduction. CONCLUSION:HIV infection perturbsIL-7 signaling by impairing the access of STAT5 to the nuclear compartment. This defect may contribute to the loss of CD4(+) T-cell populations in patients with chronically high immune activation.
Authors: Julien van Grevenynghe; Rafael A Cubas; Sandrina DaFonseca; Talibah Metcalf; Cecile L Tremblay; Lydie Trautmann; Rafick-Pierre Sekaly; John Schatzle; Elias K Haddad Journal: Cytokine Growth Factor Rev Date: 2012-06-27 Impact factor: 7.638
Authors: Rebecca B Hasley; Changwan Hong; Wenqing Li; Travis Friesen; Yoriko Nakamura; Grace Y Kim; Jung-Hyun Park; Julie A Hixon; Scott Durum; Zonghui Hu; Michael C Sneller; Raphael Oguariri; Tomozumi Imamichi; H Clifford Lane; Marta Catalfamo Journal: AIDS Date: 2013-07-31 Impact factor: 4.177
Authors: Aaruni Khanolkar; William J Muller; Bridget M Simpson; Jillian Cerullo; Ruth Williams; Sun Bae Sowers; Kiana Matthews; Sara Mercader; Carole J Hickman; Richard T D'Aquila; Guorong Liu Journal: Commun Med (Lond) Date: 2022-03-04
Authors: Benjamin Krämer; Felix Goeser; Philipp Lutz; Andreas Glässner; Christoph Boesecke; Carolynne Schwarze-Zander; Dominik Kaczmarek; Hans Dieter Nischalke; Vittorio Branchi; Steffen Manekeller; Robert Hüneburg; Tobias van Bremen; Tobias Weismüller; Christian P Strassburg; Jürgen K Rockstroh; Ulrich Spengler; Jacob Nattermann Journal: PLoS Pathog Date: 2017-05-15 Impact factor: 6.823
Authors: Alberto Bosque; Kyle A Nilson; Amanda B Macedo; Adam M Spivak; Nancie M Archin; Ryan M Van Wagoner; Laura J Martins; Camille L Novis; Matthew A Szaniawski; Chris M Ireland; David M Margolis; David H Price; Vicente Planelles Journal: Cell Rep Date: 2017-01-31 Impact factor: 9.423
Authors: Anne P Bouvy; Mariska Klepper; Michiel G H Betjes; Willem Weimar; Dennis A Hesselink; Carla C Baan Journal: Transplant Direct Date: 2016-05-25